STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
164
13F, latest reported quarter
What the filings say about TRMK
Insiders, 180 days
-$24.2K net sold
1 seller · 0% of sales under a 10b5-1 plan
Trustmark insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, TRUSTMARK CORP insiders sold a net $24.2K of stock across 27 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 18, 2025.
2 other insiders sold within 30 days.
164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director HOST GERARD R sold about $15.8K of TRMK on Aug 26, 2025; 2 other insiders sold within 30 days and 164 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Oct 30, 2024.
The trade is 8.2% of the 8,577 shares held after it.
2 other insiders sold within 30 days.
164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Eduardo Marcelo L sold about $26.9K of TRMK on Aug 18, 2025; 2 other insiders sold within 30 days and 164 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Nov 15, 2024.
The trade is 13.2% of the 158,360 shares held after it.
2 other insiders sold within 30 days.
164 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director HOST GERARD R sold about $807.1K of TRMK on Aug 18, 2025, the largest insider sale at the company on our record; 2 other insiders sold within 30 days and 164 funds added in the latest 13F quarter.
27 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
TRMK planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
TRMK mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Harbor Small Cap Value Fund
$44.1M position · as of 2026-07-31
1.8%
Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund
$2.3M position · as of 2026-06-30
1.3%
Sterling Capital Small Cap Value Fund
$2.3M position · as of 2026-06-30
1.2%
First Trust NASDAQ ABA Community Bank Index Fund
$950.5K position · as of 2026-06-30
1.1%
State Street(R) SPDR(R) S&P(R) Bank ETF
$14.0M position · as of 2026-06-30
0.9%
Invesco S&P SmallCap Low Volatility ETF
$2.0M position · as of 2026-05-31
0.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.6M
$3.7M
$1.4M
+66%
+27%
2024
$3.2M
$4.0M
$1.3M
+21%
+2%
2023
$2.8M
$2.3M
$1.1M
-8%
-22%
2022
$2.7M
$2.8M
$1.0M
+11%
-0%
2021
$2.5M
$2.7M
$1.2M
+0%
+34%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $24.2K sold by insiders over 180 days, 164 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM TRMK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM TRMK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$186.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM TRMK
FY Dec 2025
$232.0M
FY Dec 2024
$93.4M
FY Dec 2023
$156.8M
FY Dec 2022
$269.9M
FY Dec 2021
$321.4M
Jun 2026
$49.5M
Mar 2026
$20.6M
Dec 2025
$54.1M
Sep 2025
$62.7M
Jun 2025
$34.5M
Mar 2025
$80.6M
Dec 2024
$95.3M
Sep 2024
$51.2M
At each fiscal year end
Single quarter
Debt to equity
0.04x
current debt only, 2018-12-31 (91 months older than the period end); equity 2026-06-30
Debt to equity TRMK
FY Dec 2025
0.04x
FY Dec 2024
0.04x
FY Dec 2023
0.05x
FY Dec 2022
0.05x
FY Dec 2021
0.05x
Jun 2026
0.04x
Mar 2026
0.04x
Dec 2025
0.04x
Sep 2025
0.04x
Jun 2025
0.04x
Mar 2025
0.04x
Dec 2024
0.04x
Sep 2024
0.04x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
2.63x
TTM operating cash flow over current debt only, 2018-12-31 (91 months older than the period end)
Cash flow to debt TRMK
FY Dec 2025
3.09x
FY Dec 2024
1.48x
FY Dec 2023
2.49x
FY Dec 2022
3.75x
FY Dec 2021
4.41x
Jun 2026
2.63x
Mar 2026
2.39x
Dec 2025
3.09x
Sep 2025
3.61x
Jun 2025
3.53x
Mar 2025
3.26x
Dec 2024
1.48x
Sep 2024
1.04x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+11.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity TRMK
FY Dec 2025
+11.0%
FY Dec 2024
+12.3%
FY Dec 2023
+10.5%
FY Dec 2022
+4.4%
FY Dec 2021
+8.5%
Jun 2026
+11.1%
Mar 2026
+10.9%
Dec 2025
+11.0%
Sep 2025
+10.9%
Jun 2025
+11.0%
Mar 2025
+12.7%
Dec 2024
+12.3%
Sep 2024
+11.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets TRMK
FY Dec 2025
+1.2%
FY Dec 2024
+1.2%
FY Dec 2023
+0.9%
FY Dec 2022
+0.4%
FY Dec 2021
+0.9%
Jun 2026
+1.2%
Mar 2026
+1.2%
Dec 2025
+1.2%
Sep 2025
+1.2%
Jun 2025
+1.2%
Mar 2025
+1.3%
Dec 2024
+1.2%
Sep 2024
+1.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital TRMK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed TRMK
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.74x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing TRMK
FY Dec 2025
10.53x
FY Dec 2024
9.74x
FY Dec 2023
10.29x
FY Dec 2022
29.84x
FY Dec 2021
13.87x
Jun 2026
11.71x
Mar 2026
11.18x
Dec 2025
10.53x
Sep 2025
10.85x
Jun 2025
10.27x
Mar 2025
9.01x
Dec 2024
9.74x
Sep 2024
9.61x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.4B
market value at close 2026-10-27 on 2026-07-31 shares, plus current debt only, 2018-12-31 (91 months older than the period end), minus cash 2019-06-30
Enterprise value TRMK
FY Dec 2025
$2.0B
FY Dec 2024
$1.8B
FY Dec 2023
$1.4B
FY Dec 2022
$1.8B
FY Dec 2021
$1.7B
Jun 2026
$2.4B
Mar 2026
$2.2B
Dec 2025
$2.0B
Sep 2025
$2.1B
Jun 2025
$1.9B
Mar 2025
$1.8B
Dec 2024
$1.8B
Sep 2024
$1.6B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.0%
TTM free cash flow over market value at close 2026-10-27
FCF yield TRMK
FY Dec 2025
+9.9%
FY Dec 2024
+4.3%
FY Dec 2023
+9.2%
FY Dec 2022
+12.7%
FY Dec 2021
+15.9%
Jun 2026
+6.9%
Mar 2026
+6.9%
Dec 2025
+9.9%
Sep 2025
+11.4%
Jun 2025
+11.9%
Mar 2025
+11.3%
Dec 2024
+4.3%
Sep 2024
+2.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.10x
P/E over trailing EPS growth of 11%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing TRMK
FY Dec 2025
5.46x
FY Dec 2024
0.29x
FY Dec 2023
0.08x
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
1.09x
Mar 2026
n/a
Dec 2025
5.46x
Sep 2025
1.06x
Jun 2025
0.60x
Mar 2025
0.18x
Dec 2024
0.29x
Sep 2024
0.09x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
TRMK ranks highest on financial health (84th percentile) and institutional and government (73rd), and lowest on risk and compliance (16th), among Banks peers.
Profitability
61
Inputs
Return on equity+11.1% · 57 pct, sector of 327
Return on assets+1.2% · 64 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
84
Inputs
Debt to equity0.04x · 81 pct, sector of 229
Cash flow to debt2.63x · 88 pct, sector of 198
Insider conviction
33
Inputs
Net Form 4 buying (codes P and S), 180d-$24K · 65 pct, sector of 273
Insider buyers, 180d0 · 0 pct, sector of 273
Institutional and government
73
Inputs
Funds adding, latest quarter164 · 73 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
16
Inputs
Short interest, % of float+6.5% · 16 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Growth, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TRMK filings, in plain words
Are Trustmark insiders buying or selling TRMK?
In the 180 days to 2026-10-28, Trustmark insiders were net sellers, a net $24.2K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, Trustmark insiders were net sellers of TRMK, a net $24.2K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.